Country: মার্কিন যুক্তরাষ্ট্র
ভাষা: ইংরেজি
সূত্র: NLM (National Library of Medicine)
IVERMECTIN (UNII: 8883YP2R6D) (IVERMECTIN - UNII:8883YP2R6D)
Arbor Pharmaceuticals
IVERMECTIN
IVERMECTIN 5 mg in 1 g
TOPICAL
PRESCRIPTION DRUG
SKLICE® Lotion is indicated for the topical treatment of head lice infestations in patients 6 months of age and older. SKLICE Lotion should be used in the context of an overall lice management program: - Wash (in hot water) or dry-clean all recently worn clothing, hats, used bedding and towels. - Wash personal care items such as combs, brushes and hair clips in hot water. - A fine-tooth comb or special nit comb may be used to remove dead lice and nits. None. Risk Summary There are no studies with the use of SKLICE Lotion in pregnant women. Epidemiologic studies with the use of oral ivermectin during pregnancy are insufficient to inform a drug-associated risk of adverse developmental outcomes, because either the timing of administration during gestation was not accurately ascertained or the administration occurred only during the second trimester (see Data) . However, systemic exposure from topical use of ivermectin is much lower than that from oral use [see Clinical Pharmacology (12.3)]. In animal reproduct
SKLICE Lotion, 0.5% is supplied in a 4 oz (117g) laminate tube (NDC 24338-183-04). Store at room temperature 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30° C (59° to 86° F) [see USP controlled room temperature]. Do not freeze.
New Drug Application
SKLICE- IVERMECTIN LOTION ARBOR PHARMACEUTICALS ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE SKLICE LOTION SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR SKLICE LOTION. SKLICE (IVERMECTIN) LOTION, 0.5%, FOR TOPICAL USE INITIAL U.S. APPROVAL: 1996 INDICATIONS AND USAGE SKLICE Lotion is a pediculicide indicated for the topical treatment of head lice infestations in patients 6 months of age and older. (1) DOSAGE AND ADMINISTRATION For topical use only. Not for oral, ophthalmic or intravaginal use. (2) Apply SKLICE Lotion to dry hair in an amount sufficient (up to 1 tube) to thoroughly coat the hair and scalp. (2) After 10 minutes, rinse off with water. (2) For single use. Discard any unused portion. (2) DOSAGE FORMS AND STRENGTHS Lotion: 0.5% (3) CONTRAINDICATIONS None. (4) WARNINGS AND PRECAUTIONS Accidental ingestion in pediatric patients may occur: Administer only under direct adult supervision. (5.1) ADVERSE REACTIONS Most common adverse reactions (incidence <1%) are conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, and skin burning sensation. (6) TO REPORT SUSPECTED ADVERSE REACTIONS, CONTACT ARBOR PHARMACEUTICALS, LLC AT 1-866-516-4950 OR FDA AT 1-800-FDA-1088 OR _WWW.FDA.GOV/MEDWATCH_. USE IN SPECIFIC POPULATIONS Safety and effectiveness in pediatric patients below the age of 6 months have not been established. (8.4) SEE 17 FOR PATIENT COUNSELING INFORMATION AND FDA-APPROVED PATIENT LABELING. REVISED: 6/2017 FULL PRESCRIBING INFORMATION: CONTENTS* 1 INDICATIONS AND USAGE 1.1 Indication 1.2 Adjunctive Measures 2 DOSAGE AND ADMINISTRATION 3 DOSAGE FORMS AND STRENGTHS 4 CONTRAINDICATIONS 5 WARNINGS AND PRECAUTIONS 5.1 Ingestion in Pediatric Patients 6 ADVERSE REACTIONS 6.1 Clinical Trials Experience 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.4 Pediatric Use 8.5 Geriatric Use ® 10 OVERDOSAGE 11 DESCRIPTION 12 CLINICAL PHARMACOLOGY 12.1 Mechanism of Action 12.2 Pharmacodynamics 12.3 Pharmacokin সম্পূর্ণ নথি পড়ুন